Patricia Rivera Selected Research

AM 251 (AM251)

1/2016	Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor-Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators.
1/2015	Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
1/2013	Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
5/2011	Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions.
1/2011	Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Rivera Research Topics

Disease

16	Obesity 10/2022 - 01/2011
14	Body Weight (Weight, Body) 12/2020 - 01/2011
7	Neuroinflammatory Diseases 09/2021 - 11/2018
6	Insulin Resistance 10/2022 - 01/2011
6	Cocaine-Related Disorders (Cocaine Addiction) 01/2021 - 01/2013
4	Gliosis 05/2022 - 01/2013
4	Inflammation (Inflammations) 05/2022 - 01/2016
4	Alcoholism (Alcohol Abuse) 09/2021 - 06/2012
4	Fatty Liver 01/2018 - 10/2015
3	Cognitive Dysfunction 06/2022 - 01/2019
3	Memory Disorders (Memory Loss) 01/2021 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 10/2022 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 11/2020
2	Weight Loss (Weight Reduction) 06/2022 - 01/2018
2	Malnutrition (Nutritional Deficiencies) 05/2022 - 01/2016
2	Ulcerative Colitis 01/2020 - 01/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2012
2	Non-alcoholic Fatty Liver Disease 10/2015 - 04/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022
1	Tauopathies 10/2022
1	Bone Resorption 04/2021
1	Overweight 12/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Chemical and Drug Induced Liver Injury 01/2020
1	Infertility (Sterility) 07/2019
1	Binge Drinking 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Ischemia 01/2016

Drug/Important Bio-Agent (IBA)

12	EndocannabinoidsIBA 05/2022 - 01/2011
9	CannabinoidsIBA 05/2022 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2013
5	Pharmaceutical PreparationsIBA 10/2022 - 01/2013
5	LeptinIBA 10/2022 - 01/2016
5	CholesterolIBA 01/2021 - 05/2011
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2011
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2019
5	AM 251 (AM251)IBA 01/2016 - 01/2011
5	EnzymesIBA 01/2016 - 01/2013
4	Cocaine (Cocaine HCl)IBA 01/2021 - 07/2013
4	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2019 - 01/2011
4	oleoylethanolamideIBA 01/2019 - 09/2012
4	LipidsIBA 01/2016 - 01/2013
3	Ethanol (Ethyl Alcohol)IBA 01/2019 - 11/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2015
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 05/2011
3	CarbohydratesIBA 01/2014 - 04/2012
2	Flavin-Adenine Dinucleotide (FAD)IBA 06/2022 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 05/2022 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 01/2013
2	Amyloid (Amyloid Fibrils)IBA 05/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
2	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 12/2020 - 01/2016
2	LigandsIBA 01/2020 - 01/2016
2	AdiponectinIBA 01/2018 - 04/2012
2	Peroxisome ProliferatorsIBA 01/2017 - 01/2012
1	tau Proteins (tau Protein)IBA 10/2022
1	Cyclin-Dependent Kinase 5IBA 10/2022
1	pinitolIBA 10/2022
1	Insulin (Novolin)FDA Link 06/2022
1	NeuropeptidesIBA 06/2022
1	Inositol (Myoinositol)IBA 06/2022
1	Monounsaturated Fatty AcidsIBA 05/2022
1	VimentinIBA 05/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 09/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2021
1	Platelet-Derived Growth FactorIBA 01/2021
1	Becaplermin (PDGF-BB)FDA Link 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	CytokinesIBA 01/2021
1	ChemokinesIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Chemokine CX3CL1IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 12/2020
1	Lipocalin-2IBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 12/2020
1	Connective Tissue Growth FactorIBA 12/2020
1	ReninIBA 12/2020
1	AngiotensinogenIBA 12/2020
1	lysophosphatidylinositolIBA 11/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020
1	RNA Splicing FactorsIBA 07/2019
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2019
1	Neurotrophin 3IBA 01/2019
1	Coenzyme A (CoA)IBA 01/2018
1	Appetite Depressants (Anorectics)IBA 01/2018
1	Liraglutide FDA Link 11/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2016
1	PPAR alphaIBA 01/2016
1	BilirubinIBA 01/2016
1	oxidized low density lipoproteinIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	CytochromesIBA 10/2015

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2012
3	Fat-Restricted Diet (Diet, Fat Restricted) 04/2012 - 01/2011
2	Self Administration (Administration, Self) 09/2021 - 07/2013